Meienhofer Award
The Meienhofer Award was established in 2007 to biennially recognize an individual with a lifetime of achievement in peptide science.
2024 Meienhofer Award Recipient
Fernando Albericio
Dr. Fernando Albericio, Research Professor at the University of KwaZulu-Natal (South Africa) and an Emeritus Professor of Organic Chemistry at the University of Barcelona (Spain), has been named as the 2024 recipient of the Meienhofer Award for Excellence in Peptide Sciences. The award will be presented to Dr. Albericio on September 17, 2024 at the Boulder Peptide Symposium in Boulder, Colorado, where Dr. Albericio will gave a presentation of highlights from his prodigious record of research achievements.
Johannes Arnold Meienhofer
The Meienhofer Award was established in 2007 to biennially recognize an individual with a lifetime of achievement in peptide science. The award is named after Johannes Meienhofer, in honor of his transformative discoveries in solid phase peptide synthesis. Notably Meienhofer’s work demonstrated the power of medicinal chemistry in peptide pharmacology and is considered to have laid the foundation of modern synthetic peptide therapeutics.
The Meienhofer Award therefore seeks to recognize individuals who have continued in Meienhofer’s tradition of innovation in synthetic peptide therapeutics
Past Award Recipients
Dr. Stephen B. H. Kent
2022 Recipient
Professor Emeritus of Chemistry, Biochemistry and Molecular Biology at the University of Chicago
Dr. Sam Gellman
2019 Recipient
Ralph F. Hirschmann Professor of Chemistry and Vilas Research Professor at the University of Wisconsin – Madison
Dr. Daniel H. Rich
2017 Recipient
Emeritus Ralph F. Hirschmann Professor of Medicinal And Organic Chemistry at the University of Wisconsin-Madison
Dr. Richard DiMarchi
2015 Recipient
Standiford H. Cox Distinguished Professor of Chemistry and the Linda & Jack Gill Chair in Biomolecular Sciences at Indiana University
Dr. Jean Rivier
2014 Recipient
Professor in The Clayton Foundation Laboratories for Peptide Biology at the Salk Institute for Biological Studies
Dr Horst Kessler
2013 Recipient
Carl von Linde Professor, Institute for Advanced Study of Technische Universität München, Germany
Dr Victor Hruby
Dr Jean Martinez
2011 Recipient
Professor, Institut des Biomolécules Max Mousseron, Université de Montpellier, France
Dr Maurice Manning
2010 Recipient
Distinguished University Professor Department of Biochemistry and Cancer Biology Ombudsman, The University of Toledo College of Medicine and Life Sciences, USA
Dr Waleed Danho
Dr Andrew Schally
2008 Recipient
VA Distinguished Medical Research Scientist, Veterans Affairs Medical Center, Miami, USA
Dr Daniel S. Kemp
2024 Meienhofer Award Recipient
Dr. Fernando Albericio
Dr. Fernando Albericio, Research Professor at the University of KwaZulu-Natal (South Africa) and an Emeritus Professor of Organic Chemistry at the University of Barcelona (Spain), has been named as the 2024 recipient of the Meienhofer Award for Excellence in Peptide Sciences. The award will be presented to Dr. Albericio on September 17, 2024 at the Boulder Peptide Symposium in Boulder, Colorado, where Dr. Albericio will gave a presentation of highlights from his prodigious record of research achievements.
The Meienhofer Award was established in 2007 to biennially recognize an individual with a lifetime of achievement in peptide science. The award is named after Johannes Meienhofer, in honor of his transformative discoveries in solid phase peptide synthesis. Notably Meienhofer’s work demonstrated the power of medicinal chemistry in peptide pharmacology and is considered to have laid the foundation of modern synthetic peptide therapeutics.
The Meienhofer Award therefore seeks to recognize individuals who have continued in Meienhofer’s tradition of innovation in synthetic peptide therapeutics.
The Meienhofer Award was established in 2007 to biennially recognize an individual with a lifetime of achievement in peptide science. The award is named after Johannes Meienhofer, in honor of his transformative discoveries in solid phase peptide synthesis. Notably Meienhofer’s work demonstrated the power of medicinal chemistry in peptide pharmacology and is considered to have laid the foundation of modern synthetic peptide therapeutics.
The Meienhofer Award therefore seeks to recognize individuals who have continued in Meienhofer’s tradition of innovation in synthetic peptide therapeutics.
Past Award Recipient
Dr. Stephen B. H. Kent
Dr. Sam Gellman
Dr. Daniel H. Rich
Dr. Richard diMarchi
Dr. Jean Rivier
Dr Horst Kessler
Dr Victor Hruby
Dr Jean Martinez
Dr Maurice Manning
Dr Waleed Danho
Dr Andrew Schally
